Nav: Home

DMP 'chronic heart failure': Guidelines do not cover all health-care aspects

January 22, 2016

On 15 January 2016 the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a search for evidence-based guidelines on the treatment of people with chronic heart failure. The aim of the report is to identify those recommendations from current guidelines of high methodological quality that may be relevant for the potential new disease management programme (DMP) "Chronic heart failure".

According to the results of the report the recommendations are largely consistent, but do not cover all health care aspects. The new European guideline planned for publication in spring 2016 could contain important additional Information.

A total of 22 guidelines included

The 22 guidelines that IQWiG could include and analyse address a wide range of health care aspects. Besides diagnostic procedures and non-drug interventions, including lifestyle changes, the guideline recommendations cover drugs as well as interventional therapies in the form of cardiac resynchronization or implantable defibrillators. The recommendations also cover monitoring, patient training, palliative care of patients with end-stage disease, and care of pregnant patients. In addition, recommendations could be identified on right heart failure and the long-term management of patients with heart failure living in nursing homes. The corresponding recommendations are largely consistent.

Gaps for certain concomitant diseases

Patients with heart failure very often suffer from further diseases also requiring treatment. It is thus surprising that even for common concomitant diseases such as renal failure, diabetes mellitus or chronic obstructive pulmonary disease (COPD), guidelines lack recommendations. In addition, the care of multimorbid patients and polypharmacy (i.e. the simultaneous use of different drugs) are insufficiently considered.

Switch between chronic and acute stages

While chronic heart failure develops over a longer period of time, acute heart failure occurs suddenly, for instance, after a severe heart attack. It is typical of the disease that the disease stage changes and patients switch between the chronic and acute stages. This implies that, in the chronic stage, patients are treated in the outpatient setting; in the event of acute and often life-threatening deterioration (decompensation) they are hospitalized and after overcoming the acute situation, are then treated as outpatients again.

Provision of continuous care inadequately depicted in guidelines

However, acute and chronic disease stages are presented separately in guidelines. The commission awarded to IQWiG by the Federal Joint Committee (G-BA) was explicitly restricted to guidelines on chronic heart failure. In this respect, the relatively common transitions between the outpatient and inpatient sectors, which are typical for the disease, are in part only inadequately depicted.

Information from guidelines alone is thus probably insufficient to define optimal care pathways for a DMP. The G-BA may therefore use further information sources in order to formulate the requirements for the future DMP.

The European Society of Cardiology plans to publish an updated guideline in May 2016. Health care experts expect this guideline to include important information that could be incorporated in the DMP. This applies in particular to cardiac resynchronization and treatment of patients with heart failure also suffering from sleep apnoea.
-end-
Procedure of report production

IQWiG published the preliminary results in the form of the preliminary report in July 2015 and interested parties were invited to submit comments. When the commenting procedure ended, the preliminary report was revised and sent as a final report to the commissioning agency, the Federal Joint Committee, in November 2015. The written comments submitted are published in a separate document at the same time as the final report. The report was produced in collaboration with external experts.

The English translation of the report will be available soon. If you would like to be informed when the English document is available, please send an e-mail to » info@iqwig.de.

Institute for Quality and Efficiency in Health Care

Related Heart Failure Articles:

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population
Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.
Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.
Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.
Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.
How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.
Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
NSAID impairs immune response in heart failure, worsens heart and kidney damage
Non-steroidal anti-inflammatory drugs, or NSAIDs, are widely known as pain-killers and can relieve pain and inflammation.
Heart cell defect identified as possible cause of heart failure in pregnancy
A new Tel Aviv University study reveals that one of the possible primary causes of heart failure in pregnant women is a functional heart cell defect.
In heart failure, a stronger heart could spell worse symptoms
Patients with stronger-pumping hearts have as many physical and cognitive impairments as those with weaker hearts, suggesting the need for better treatment.
More Heart Failure News and Heart Failure Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.